Latest Insider Transactions at G1 Therapeutics, Inc. (GTHX)
This section provides a real-time view of insider transactions for G1 Therapeutics, Inc. (GTHX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of G1 Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of G1 Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2021
|
Rajesh Malik Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+21.37%
|
$60,000
$4.17 P/Share
|
|
Jan 21
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-19.61%
|
$200,000
$20.64 P/Share
|
|
Jan 21
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.39%
|
$30,000
$3.72 P/Share
|
|
Jan 20
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+13.22%
|
$28,000
$2.06 P/Share
|
|
Jan 20
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-21.28%
|
$210,000
$21.51 P/Share
|
|
Jan 19
2021
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-21.28%
|
$200,000
$20.88 P/Share
|
|
Jan 19
2021
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.54%
|
$30,000
$3.72 P/Share
|
|
Jan 04
2021
|
Mark Avagliano Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jan 04
2021
|
Terry L Murdock Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jan 04
2021
|
Rajesh Malik Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+21.48%
|
-
|
|
Jan 04
2021
|
James S. Hanson General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+42.31%
|
-
|
|
Jan 04
2021
|
Soma Gupta Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jan 04
2021
|
Jennifer K. Moses CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+33.33%
|
-
|
|
Jan 01
2021
|
John E. (Jack) Bailey Jr. President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
213,333
+49.08%
|
-
|
|
Dec 24
2020
|
Seth Rudnick |
SELL
Open market or private sale
|
Indirect |
924
-14.93%
|
$18,480
$20.1 P/Share
|
|
Dec 23
2020
|
Seth Rudnick |
SELL
Open market or private sale
|
Indirect |
13,118
-67.94%
|
$262,360
$20.18 P/Share
|
|
Dec 22
2020
|
Seth Rudnick |
SELL
Open market or private sale
|
Indirect |
18,974
-49.56%
|
$379,480
$20.33 P/Share
|
|
Dec 17
2020
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-21.28%
|
$190,000
$19.97 P/Share
|
|
Dec 17
2020
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.54%
|
$30,000
$3.72 P/Share
|
|
Dec 16
2020
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-21.28%
|
$190,000
$19.2 P/Share
|
|
Dec 16
2020
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.54%
|
$30,000
$3.72 P/Share
|
|
Dec 15
2020
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
10,000
-21.28%
|
$190,000
$19.43 P/Share
|
|
Dec 15
2020
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.54%
|
$30,000
$3.72 P/Share
|
|
Dec 10
2020
|
Rajesh Malik Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,000
-23.56%
|
$180,000
$20.06 P/Share
|
|
Dec 10
2020
|
Rajesh Malik Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+19.07%
|
$36,000
$4.17 P/Share
|
|
Dec 10
2020
|
Seth Rudnick |
SELL
Open market or private sale
|
Indirect |
546
-1.41%
|
$10,920
$20.0 P/Share
|
|
Dec 09
2020
|
Seth Rudnick |
SELL
Open market or private sale
|
Indirect |
5,773
-12.94%
|
$115,460
$20.32 P/Share
|
|
Dec 08
2020
|
Seth Rudnick |
SELL
Open market or private sale
|
Indirect |
13,161
-22.78%
|
$263,220
$20.19 P/Share
|
|
Dec 01
2020
|
Seth Rudnick |
SELL
Open market or private sale
|
Indirect |
520
-0.89%
|
$10,400
$20.09 P/Share
|
|
Nov 18
2020
|
Glenn P Muir |
BUY
Open market or private purchase
|
Direct |
50,000
+22.63%
|
$650,000
$13.5 P/Share
|
|
Nov 11
2020
|
John E. (Jack) Bailey Jr. President and CEO |
BUY
Open market or private purchase
|
Direct |
4,000
+33.33%
|
$48,000
$12.83 P/Share
|
|
Nov 10
2020
|
John E. (Jack) Bailey Jr. President and CEO |
BUY
Open market or private purchase
|
Direct |
4,000
+50.0%
|
$48,000
$12.76 P/Share
|